No abstract available
MeSH terms
-
Antibodies, Monoclonal, Humanized* / adverse effects
-
Antibodies, Monoclonal, Humanized* / therapeutic use
-
Brain Ischemia / diagnostic imaging
-
Brain Ischemia / drug therapy
-
Cerebral Hemorrhage* / chemically induced
-
Cerebral Hemorrhage* / diagnostic imaging
-
Fibrinolytic Agents* / adverse effects
-
Fibrinolytic Agents* / therapeutic use
-
Humans
-
Intracranial Hemorrhages / chemically induced
-
Intracranial Hemorrhages / diagnostic imaging
-
Stroke* / diagnostic imaging
-
Stroke* / drug therapy
-
Tissue Plasminogen Activator* / adverse effects
-
Tissue Plasminogen Activator* / therapeutic use
-
Treatment Outcome
Substances
-
Fibrinolytic Agents
-
lecanemab
-
Tissue Plasminogen Activator
-
Antibodies, Monoclonal, Humanized